参考文献：

[1]Pedersen TR.Scandinavian Simvastatin Survival Study Group.Randomized trial of cholesterol-lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study I (4S)[J].Lancet,1994,344(8934):1383-1389
[2]Shepherd J,Cobbe SM,Ford 1,et al.West of Scotland Coronary Prevention Study Group.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia[J].N EngI J Med,1995,333(20):1301-1308
[3]Sacks FM,Pfeffer MA,Moye LA,et al.The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.Cholesterol and Recurrent Events Trial Investigators[J].N EngI J Med,1996,335(14):1001-1009
[4]LIPID Study Group.Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study:a randomized trial in patients acute myocardial infarction and / or unstable angina pectoris[J].Am J Cardiol,1995,76 (7):474-483
[5]Downs JR,Clearfield M.Weis S,et al.Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels:results of AFCAPS / Tex CAPS[J].JAMA,1998,299 (20):1615-1622
[6]王水强.西立伐他汀治疗原发性高胆固醇血症随机对照研究[J].中华心血管杂志,2000,28(4)259-263
[7]陈巧云,魏水易,陆晓和.他汀类降脂药物在冠心病防治中的地位[J].药品评价,2005,2(2):149-151
[8]Schwartz G G,Olsson A G,Ezekowitz M D,et al.Effects of atorvsstatin on early recurrent ischemia events in acute coronary syndrome.The MIRACL Study,A randomized clinical trial[J].JAMA,2001,285 (3):1711-1718
[9]Dupuis J,Tardif T C,Throux P.Cholesterol reduction rapidly improved endothelial function after acute coronary syndrome[J].J Am Coll Cardiol,1998,31 (Suppl A):S891-S897
[10]马立宁,江宁,张丽.辛伐他汀在急性冠脉综合征中的应用[J].中国临床保健杂志,2005,8(2):129-130
[11]Vaugham CJ.Prevention of stroke and dementia with statins:effects beyond lipid lowering[J].Am J Cardiol,2003,91 (3 suppl) S23-S29
[12]PRC-USA Cardiovascular and Cardiopulmonary Epidemiology Research Group.An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the Pepole's Republic of China.Baseline report from the PRC-USA collaborative study[J].Circulation,1992,85:1083-1089
[13]刘志军,范生尧.他汀类药物预防缺血性卒中及其机制的研究进展[J].国外医学脑血管疾病分册,2003,11(4):260-262
[14]王宁霞.缺血性脑卒中后服用他汀类药物可改善转归[J].国外医学脑血管疾病分册,2003,11(3):177-179
[15]Papassotiropoulos A,Lutjohann D.Bagli M et al.24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia[J].J Psychiatr Res,2002,36 (1):27-32
[16]Michikawa M.Cholesterol paradox:is high total or low HDL cholesterol level a risk for Alzheimer'S disease[J].J Neurosci Res,2003,72 (2):141-146
[17]Wood G.Eckert GP,lgbavboa U,et al.Amyloid beta-protein interactions with membranes and cholesterol:causes or casualties of Alzheimer's disease[J].Biochim Biophys Acta,2003,1610 (2):281-290
[18]Kirsh C,Eckert GP,Mueller WE.Statin effects on cholesterol micro-domains in brain plasma membranes[J].Biochem Pharmacol,2003.65 (5):843-856
[19]Hajjar 1,Schumpert J,Hirth V.The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment[J].J Gerontol Biol Sci Med Sci,2002.57 (7):414-418
[20]Jick.H,Zornberg GL,Jick SS,et al.Statns and the risk of dementis[J].Lancet,2000:356(9242):1627-1631